AQR Capital Management’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-34,981
| Closed | -$106K | – | 2371 |
|
|
2022
Q2 | $106K | Sell |
34,981
-56,290
| -62% | -$171K | ﹤0.01% | 2084 |
|
|
2022
Q1 | $620K | Sell |
91,271
-70,155
| -43% | -$477K | ﹤0.01% | 1735 |
|
|
2021
Q4 | $1.35M | Sell |
161,426
-5,766
| -3% | -$48.1K | ﹤0.01% | 1406 |
|
|
2021
Q3 | $1.24M | Buy |
167,192
+11,240
| +7% | +$83.5K | ﹤0.01% | 1431 |
|
|
2021
Q2 | $1.06M | Buy |
155,952
+7,657
| +5% | +$52K | ﹤0.01% | 1559 |
|
|
2021
Q1 | $1.52M | Sell |
148,295
-48,363
| -25% | -$497K | ﹤0.01% | 1361 |
|
|
2020
Q4 | $1.38M | Sell |
196,658
-6,078
| -3% | -$42.6K | ﹤0.01% | 1353 |
|
|
2020
Q3 | $1.65M | Sell |
202,736
-251,738
| -55% | -$2.05M | ﹤0.01% | 1194 |
|
|
2020
Q2 | $3.14M | Sell |
454,474
-168,021
| -27% | -$1.16M | 0.01% | 958 |
|
|
2020
Q1 | $2.96M | Buy |
+622,495
| New | +$2.96M | 0.01% | 940 |
|
|
2019
Q3 | – | Sell |
-288,422
| Closed | -$1.43M | – | 2186 |
|
|
2019
Q2 | $1.43M | Sell |
288,422
-98,753
| -26% | -$489K | ﹤0.01% | 1371 |
|
|
2019
Q1 | $2.4M | Buy |
387,175
+255,732
| +195% | +$1.59M | ﹤0.01% | 1241 |
|
|
2018
Q4 | $443K | Buy |
+131,443
| New | +$443K | ﹤0.01% | 1821 |
|